MUNRO MEDICAL SOLUTIONS LIMITED

Company Registration Number:
12938450 (England and Wales)

Unaudited statutory accounts for the year ended 31 October 2023

Period of accounts

Start date: 01 November 2022

End date: 31 October 2023

MUNRO MEDICAL SOLUTIONS LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2023

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

MUNRO MEDICAL SOLUTIONS LIMITED

Company Information

for the Period Ended 31 October 2023




Director: Philip Swart
Eliza Swart
Registered office: 7 Three Rivers Business Park
Felixstowe Road
Foxhall
Ipswich
GBR
IP10 0BF
Company Registration Number: 12938450 (England and Wales)

MUNRO MEDICAL SOLUTIONS LIMITED

Directors' Report Period Ended 31 October 2023

The directors present their report with the financial statements of the company for the period ended 31 October 2023

Principal Activities

Provide Medical Training Courses and sell First Aid equipment

Directors

The directors shown below have held office during the whole of the period from 01 November 2022 to 31 October 2023
Philip Swart
Eliza Swart

This report was approved by the board of directors on 19 March 2024
And Signed On Behalf Of The Board By:

Name: Philip Swart
Status: Director

MUNRO MEDICAL SOLUTIONS LIMITED

Balance sheet

As at 31 October 2023


Notes

2023
£

2022
£
Fixed assets
Intangible assets: 4 0 0
Tangible assets: 5 0 0
Total fixed assets: 0 0
Current assets
Stocks: 0
Debtors: 6 0 0
Cash at bank and in hand: 17 17
Total current assets: 17 17
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 7 ( 0 ) ( 0 )
Net current assets (liabilities): 17 17
Total assets less current liabilities: 17 17
Creditors: amounts falling due after more than one year: 8 ( 0 ) ( 0 )
Provision for liabilities: ( 0 )
Accruals and deferred income: ( 0 )
Total net assets (liabilities): 17 17

The notes form part of these financial statements

MUNRO MEDICAL SOLUTIONS LIMITED

Balance sheet continued

As at 31 October 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 17 17
Revaluation reserve: 9 0 0
Profit and loss account: 0
Shareholders funds: 17 17

For the year ending 31 October 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 19 March 2024
And Signed On Behalf Of The Board By:

Name: Philip Swart
Status: Director

The notes form part of these financial statements

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 2 2

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

  • 3. Off balance sheet disclosure

    No

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

4. Intangible assets

Goodwill Total
Cost £ £
At 01 November 2022 0 0
Additions 0 0
Disposals ( 0 ) ( 0 )
Revaluations 0 0
Transfers 0 0
At 31 October 2023 0 0
Amortisation
Amortisation at 01 November 2022 0 0
Charge for year 0 0
On disposals ( 0 ) ( 0 )
Other adjustments 0 0
Amortisation at 31 October 2023 0 0
Net book value
Net book value at 31 October 2023 0 0
Net book value at 31 October 2022 0 0

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

5. Tangible assets

Office equipment Total
Cost £ £
At 01 November 2022 0 0
Additions 0 0
Disposals ( 0 ) ( 0 )
Revaluations 0 0
Transfers 0 0
At 31 October 2023 0 0
Depreciation
At 01 November 2022 0 0
Charge for year 0 0
On disposals ( 0 ) ( 0 )
Other adjustments 0 0
At 31 October 2023 0 0
Net book value
At 31 October 2023 0 0
At 31 October 2022 0 0

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

6. Debtors


2023
£

2022
£
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 0
Total 0 0
Debtors due after more than one year: 0 0

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

7.Creditors: amounts falling due within one year note


2023
£

2022
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 0 0
Other creditors 0 0
Total 0 0

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

8.Creditors: amounts falling due after more than one year


2023
£

2022
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 0 0
Total 0 0

MUNRO MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2023

9. Revaluation reserve


2023
£
Balance at 01 November 2022 0
Surplus or deficit after revaluation 0
Balance at 31 October 2023 0